Masimo Corporation (NASDAQ:MASI) EVP Yongsam Lee sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, January 13th. The shares were sold at an average price of $72.00, for a total transaction of $720,000.00. Following the transaction, the executive vice president now directly owns 79,000 shares in the company, valued at $5,688,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Yongsam Lee also recently made the following trade(s):
Masimo Corporation (NASDAQ:MASI) traded up 0.87% during mid-day trading on Wednesday, reaching $72.19. 382,194 shares of the company’s stock traded hands. Masimo Corporation has a 1-year low of $33.03 and a 1-year high of $72.20. The stock has a market cap of $3.59 billion, a P/E ratio of 34.86 and a beta of 1.02. The firm has a 50-day moving average price of $66.70 and a 200-day moving average price of $59.83.
Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.42 by $0.10. The business had revenue of $167.60 million for the quarter, compared to the consensus estimate of $165.51 million. Masimo Corporation had a net margin of 16.31% and a return on equity of 29.42%. Masimo Corporation’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same period last year, the company posted $0.36 EPS. Equities research analysts anticipate that Masimo Corporation will post $2.14 EPS for the current fiscal year.
A number of research analysts recently commented on the stock. Wedbush reaffirmed an “outperform” rating and set a $63.00 price objective on shares of Masimo Corporation in a research report on Thursday, November 3rd. Zacks Investment Research downgraded shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research report on Monday, January 9th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Masimo Corporation currently has a consensus rating of “Buy” and a consensus target price of $55.00.
Several hedge funds have recently made changes to their positions in MASI. D.A. Davidson & CO. increased its stake in shares of Masimo Corporation by 42.8% in the third quarter. D.A. Davidson & CO. now owns 1,713 shares of the company’s stock worth $101,000 after buying an additional 513 shares in the last quarter. Victory Capital Management Inc. increased its stake in shares of Masimo Corporation by 76.9% in the second quarter. Victory Capital Management Inc. now owns 2,148 shares of the company’s stock worth $113,000 after buying an additional 934 shares in the last quarter. Acrospire Investment Management LLC increased its stake in shares of Masimo Corporation by 22.2% in the third quarter. Acrospire Investment Management LLC now owns 2,200 shares of the company’s stock worth $131,000 after buying an additional 400 shares in the last quarter. Tower Research Capital LLC TRC purchased a new stake in shares of Masimo Corporation during the second quarter worth $116,000. Finally, First Quadrant L P CA purchased a new stake in shares of Masimo Corporation during the third quarter worth $138,000. Institutional investors and hedge funds own 82.28% of the company’s stock.
Masimo Corporation Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.